Concepedia

Yan Wang

YW

Statistics

Publications

4

Citations

123

H-Index

4

Active since

2023

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Yan Wang is an author at The University of Texas MD Anderson Cancer Center specializing in metastatic breast cancer treatment, oncology, and cdk inhibitors.

ORCID

Publications per year

2023–2025

4

Publications

4

Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers

Juliana Navarro-Yepes, Nicole M. Kettner, Xiayu Rao et al. · Cancer Research · 2023 · 52 citations · Full text

, , +17

Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer

Linjie Luo, Peng Yang, Sofia Mastoraki et al. · Molecular Cancer · 2025 · 39 citations · Full text

, , +17

Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2− breast cancer

Akshara Singareeka Raghavendra, Nicole M. Kettner, Danielle Kwiatkowski et al. · npj Breast Cancer · 2025 · 18 citations · Full text

, , +17

Low–Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer

Mi Li, Amriti R. Lulla, Yan Wang et al. · Cancer Research · 2024 · 14 citations · Full text

, , +17

1–4 of 4